Skip to Main Content

Paper Details

Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study.
Elife
8
2022
COVID-19, CXCL10, IFN, MCP-2, MCP-3, MCP1, Peginterferon lambda, SARS, SARS-, SARS-CoV, SARS-CoV-2, T cell, T cell memory, mRNA, patient, patients, plasma RIG-I, severe acute respiratory syndrome-related coronavirus 2
Author NameAffiliation
Prabhu S ArunachalamInstitute for Immunity, Stanford University
Jason R AndrewsStanford University
Atul J ButteBakar Computational Health Sciences Institute, University of California san francisco
Bali PulendranInstitute for Immunity, Stanford University
Bali PulendranStanford University
Bali PulendranStanford University
Bali PulendranInstitute for Immunity, Stanford University
Bali PulendranStanford University
Bali PulendranStanford University
  • 1 - 9

Datasets

Release 1.2